139.40MMarket Cap
LossP/E TTM
ENTX Balance Sheet
You can check out the annual or quarterly balance sheets of Entera Bio Ltd here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing ENTX stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Entera Bio Ltd Have?
In its most recent quarterly, Entera Bio Ltd had 4.14M in cash and cash equivalents.
How Much Are Entera Bio Ltd's Total Liabilities?
Entera Bio Ltd reported 2.89M in total liabilities as of the latest reported quarter, including 2.20M in current liabilities and 689.00K in non-current liabilities.
What Are Entera Bio Ltd's Total Assets?
As of the latest reported quarter, Entera Bio Ltd's total assets were 15.99M, consisting of 15.30M in current assets and 695.00K in non-current assets.
How Much Shareholders' Equity Does Entera Bio Ltd Have?
Entera Bio Ltd reported 13.10M in total shareholders' equity as of the latest reported quarter.